Shanghai Shen Lian Biomedical (SHSE:688098) Tariff Resilience Score: 0/10 (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688098 Shanghai Shen Lian Biomedical Corp SHSE:688098
70 GF Score
Price ¥8.41
GF Value ¥5.85
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shanghai Shen Lian Biomedical Tariff Resilience Score?

Shanghai Shen Lian Biomedical has the Tariff Resilience Score of 0, which implies that the company might have .

Shanghai Shen Lian Biomedical has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Shanghai Shen Lian Biomedical might have .

Shanghai Shen Lian Biomedical  (SHSE:688098) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Shanghai Shen Lian Biomedical Tariff Resilience Score Related Terms

SHSE:688098
70GF Score
Shanghai Shen Lian Biomedical Corp SHSE:688098
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Shen Lian Biomedical (SHSE:688098) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical stock appears to be overvalued. The current stock price of ¥8.41 is trading 43.8% above its estimated GF Value™ of ¥5.85. GuruFocus considers Shanghai Shen Lian Biomedical to be Significantly Overvalued.

Key valuation signals for SHSE:688098:

  • Tariff Resilience Score: 0
  • GF Value™: ¥5.85 vs. price of ¥8.41 (43.8% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688098 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Shen Lian Biomedical Business Description

Address No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
70GF Score

Get the complete analysis for SHSE:688098

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.41
Price
¥5.85
GF Value